A randomized study of solriamfetol for excessive sleepiness in narcolepsy

OBJECTIVE: Solriamfetol (JZP‐110) is a selective dopamine and norepinephrine reuptake inhibitor with wake‐promoting effects. This phase 3 study (NCT02348593) evaluated the safety and efficacy of solriamfetol in narcolepsy. METHODS: Patients with narcolepsy with mean sleep latency <25 minutes on t...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorpy, Michael J., Shapiro, Colin, Mayer, Geert, Corser, Bruce C., Emsellem, Helene, Plazzi, Giuseppe, Chen, Dan, Carter, Lawrence P., Wang, Hao, Lu, Yuan, Black, Jed, Dauvilliers, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593450/
https://www.ncbi.nlm.nih.gov/pubmed/30694576
http://dx.doi.org/10.1002/ana.25423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593450/
https://www.ncbi.nlm.nih.gov/pubmed/30694576
http://dx.doi.org/10.1002/ana.25423

Ejemplares similares